SCHEMBL17429642

SCHEMBL17429642

COC(=O)c1ccc(CCCc2cccc(C)c2)c(Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4A11 Q02928 5/20 0.52
▸ CYP4F2 P78329 4/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ MAPT P10636 1/20 0.50
▸ ALOX12 P18054 1/20 0.50
▸ P4HB P07237 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.45
▸ LOXL2 Q9Y4K0 1/20 0.44
▸ CCR6 P51684 1/20 0.43
▸ HKDC1 Q2TB90 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NOTUM Q6P988 1/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17429649 0.89 P4HB (0.46) CYP4A11CYP4F2MAPTALOX12P4HB
SCHEMBL17386069 0.87 HDAC1 (0.53) CYP4A11CYP4F2MEN1KMT2AP4HB
SCHEMBL17386083 0.83 P4HB (0.43) CYP4A11CYP4F2MAPTP4HBKDM4E
SCHEMBL1560837 0.83 CYP4F2 (0.52) CYP4A11CYP4F2MEN1KMT2AMAPT
SCHEMBL17429703 0.79 P4HB (0.45) CYP4A11CYP4F2MEN1KMT2AP4HB
SCHEMBL17429646 0.78 CYP4A11 (0.45) CYP4A11CYP4F2MEN1KMT2AMAPT
SCHEMBL1995897 0.77 MEN1 (0.49) CYP4A11CYP4F2MEN1KMT2AMAPT
SCHEMBL27594634 0.76 NOTUM (0.53) CYP4A11CYP4F2MEN1KMT2AMAPT
SCHEMBL17385775 0.76 NPC1 (0.56) CYP4A11CYP4F2MEN1KMT2AMAPT
SCHEMBL17429644 0.76 NOTUM (0.45) CYP4A11CYP4F2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 CYP4A11 159/4885CYP4F2 958/4885MEN1 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback